For additional information, please call (858) 534-5815 or email us at invent@ucsd.edu.
| Case No. | Title | Description |
Zebrafish Model for Atherosclerosis |
UC San Diego researchers have developed a novel zebrafish model useful for studying mechanisms of accumulation of lipid in blood vessel walls and associated vascular inflammation. |
|
| SD2005-116 | Fluorescent Nucleoside Analogs that Mimic Naturally Occurring Nucleosides | This invention describes synthesis, compositions, and methods related to the use of fluorescent nucleoside analogs as probes for nucleic-acid structure, dynamics, and function, as well as sequence and lesion analysis. |
| SD2005-108 | Lectin Type Fold as a Scaffold for Massive Sequence Variation | This invention provides a new class of high affinity binding proteins, based on a modified C-type lectin (CLec)-fold like structure, with a broad range of binding specificities (~1020 unique variations). |
| SD2004-209 | Monoclonal Antibodies to Rat Giantin and Drosphila Golgi Integral Membrane Protein | These two antibodies are generated to Golgi associated proteins. These are useful tools for monitoring Golgi-specific functions: structure and protein transport in cells (mammalian and Drosophila, respectively).
Related Materials: For anti-giantin: Lesa GM, Seemann J, Shorter J, Vandekerckhove J, Warren G. The amino-terminal domain of the golgi protein giantin interacts directly with the vesicle-tethering protein p115. For anti-Golgi integral membrane protein: Stanley H, Botas J, Malhotra V. The mechanism of Golgi segregation during mitosis is cell type-specific. |
| SD2003-277 | Polyclonal Antibodies to Drosophila Chromatin Assembly Factors Asf1 and p55 Subunit of CAF-1 | These are rabbit polyclonal antibodies against proteins that are involved in the assembly of chromatin. The antibodies recognize Drosophila Asf1 and Drosophila p55 subunit of CAF-1 (chromatin assembly factor-1).
Related Materials: Tyler JK, Collins KA, Prasad-Sinha J, Amiott E, Bulger M, Harte PJ, Kobayashi R, Kadonaga JT. Interaction between the Drosophila CAF-1 and ASF1 chromatin assembly factors. Mol Cell Biol. 2001 Oct;21(19):6574-84. |
| SD2002-219 | Reagents to Block Cell Division |
An antibody to the C terminal fragment of the Golgi protein GRASP65, acting intracellularly, prevents entry of cells into mitosis. Targeting GRASP65 in the Golgi could be a novel way to screen compounds for anti-cancer activity by preventing the fragmentation of the Golgi and thereby preventing entry of cells into mitosis. |
SD2001-224 and SD2001-225
|
Monoclonal and Polyclonal Antibodies Directed Against Myosin Motors— Useful for the Study of Deafness
|
Both monoclonal antibodies (SD2001-224)and polyclonal antibodies (SD2001-225) have been prepared which bind to the unconventional myosin, myosin VIIa, an actin-bindin protein, which has been shown to be involved in auditory signal transmission and may be useful for the biochemical and immunohistochemical research on deafness, blindness, and phagocytic events. |
SD2001-093 |
LJ-26, A Recombinant Chicken Monoclonal Antibody with Defined Molecular Specificity for Antibody VH Regions |
Recombinant avian antibody obtained by phage display technology. (See reference.)
|
| SD2000-066 | Kinesin Antibodies - KIF21A & KIF21B | Kinesin proteins are used by neurons for transport along microtubules. The A protein is found throughout neurons while the B protein is enriched in dendrites. Antibodies were raised against these two newly discovered kinesins with amino acid similarity, but different localizations. The antibodies are affinity purified and were raised again fusion proteins containing amino acids 1124-1355 (A) and 1135-1419 (B). (See reference.) |
SD1999-129 |
Polyclonal Antibodies to IRF3 |
Polyclonal antibodies to IRF3 have been prepared by immunizing rabbits with full-length human IRF3 fused to glutathione S-transferase. These antibodies are suitable for use in immunoprecipitations, western blotting, immunofluorescence and supershift assays. Reactive with human and bovine IRF3, weakly cross-reactive with murine IRF3. Related Materials: Navarro, L. and David, M. Journal of Biological Chemistry Vol. 274, No. 50 (1999), 35535-38. |
| SD1999-128 | Stat1 Polyclonal Antibodies | Polyclonal antibodies to STAT1 have been prepared in rabbits and are suitable for use in immunoassays. |
| SD1997-107 | Monoclonal Antibodies to PP2A |
Inquiries To: invent@ucsd.edu |
| SD1997-106 | Polyclonal Sera to Deformed Homeobox Proteins |
Inquiries To: invent@ucsd.edu |
| SD1996-079 | Polyclonal Antibodies to Kinesin | Highly specific polyclonal antibody preparations are available that target kinesin molecular motors from a number of sources. These can be used for immunostaining, or functional inactivation of molecular motor function. The preparations are available as non-patented tangible research materials under an appropriate material transfer agreement for non-commercial purposes, or for resale as laboratory reagents under a non-exclusive bailment license. |
| SD1995-179 | Monoclonal Antibodies to Anti-Rat Alcohol Dehydrogenase |
Inquiries To: invent@ucsd.edu |
| SD1982-297 | Monoclonal Antibodies to Rat NA+/K+ PUMP (ATPase) | Inquiries To: invent@ucsd.edu |
| Cell Lines | ||
| Case No. | Title | Description |
| SD2009-215 | Murine Pancreatic-Cancer Cell Lines | This technology pertains to murine pancreatic-cancer cell lines that grow in immunocompetent mice and possess genetic mutations that mirror those found in the human disease. One line rapidly and reliably metastasizes to the liver. |
SD2003-215 |
Improved Yeast Two-Hybrid Screen to Identify Small Molecules that Inhibit Protein-Protein Interactions | UC San Diego investigators have improved a version of the reverse two hybrid screen designed for the purpose of screening large chemical libraries of inhibitors of a given protein-protein interaction. They have created a small molecule permeable reporter yeast strain, a positive control activator and a panel of selective inhibitors which serve as positive controls. These improvements may significantly increase the probability of identifying a small molecule inhibitor of any protein-protein interaction that can be detected by two-hybrid analysis. |
| SD2003-185 | Chronic Lymphocytic Leukemia B Cells | These cells can be used to study the expression of zeta-associated protein 70 (ZAP-70). See the following publication for additional details.
Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A, Kipps TJ. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 2002 Dec 15;100(13):4609-14. |
| SD2003-058 | Monoclonal Antibodies to Soluble Human MD-2 | MD-2 is an adapter protein of
an innate immunity receptor, toll-like receptor 4. Thirteen
hybridoma cell lines have been generated that produce
mAbs specific to soluble human MD-2. These Abs have been
characterized and have applications in immunological assays
and functional studies. Some of the mAbs cross-react with
mouse MD-2.
Related Materials: Viriyakosol, S., Tobias, P.S., Kitchens, R.L. and Kirkland., T.N. (2001) J.Biol.Chem. 276: 38044-38051 |
| SD2000-027 | Siglec Proteins and Producing Cell Lines | Siglecs represent a new group of sialic acid binding lectims that are selectively expressed in certain cell types and are targets for tyrosine phosphrylation. A role for certain siglec proteins has been proposed for leptin physiology. (reference) |
| SD2000-023 | Cells Without Hypoxic Response | A unique embryonic stem cell line with a reduced transcriptional response to hypoxia. The cell line was created by targeting the murine HIF-1-alpha gene. It is useful for studies involving the regulation of target genes involved in the regulation of tissue oxygenation, including tumor vascularization and angiogenesis. Teratocarcinomas formed from these HIF-1a null ES cells displayed a 75% reduction in size compared to those from wild type ES cells. (reference) |
| SD2000-014 | Pituitary Progenitor Cell Line (alpha T1-1) | A mammalian cell line immortalized at a specific stage of development. Targeted oncogenesis using a fragment of the LH- alpha promoter linked to T-antigen resulted in this progenitor cell which expresses only the a-subunit of the human gene. This cell line represents a more primitive or less differentiated state of pituitary development. (reference) |
| SD2000-005 | pNEU Plasmids and Tg1-1 Cell Line | Overexpression of the neu oncogene is a factor in a significant percentage of all human breast cancers and is correlated with reduced survival and higher recurrence. This plasmid was developed to study the protective effects of the neu gene when used as a naked DNA vaccine. The expression vector encode either a 1) full length neu gene, 2) a truncated gene lacking the cytoplasmic kinase doman or 3) a truncated gene lacking both the cytoplasmic and transmembrane domains. The Tg1-1 cell line was established from a neu-expressing mammary tumor which arose spontaneously in a FVB/N neu-transgenic mouse. (reference) |
| SD1999-150 | Immortalized Presenilin (PS-1) Fibroblasts | Presenilin-1 is required for the production of beta-amyloid. The homozygous deficient and the hemizygous knock-out companion cell lines comprise a family of cell lines to study the biology of the presenilin protein and the production pathways of amyloid precursor protein and beta-amyloid protein. Four immortalized cell lines are available:
|
| SD1999-079 | Novel Thyrotrope Cell Line: T-alpha-T1 | A unique fully differentiated, clonal mouse thyrotrope cell line. This line is useful for studies of thyrotrope specific and thyroid hormone regulated TSH gene expression. (See reference.) |
| SD1998-005 | Leutenizing Hormone Secreting Cell Line | This cell line expresses the alpha and beta subunits of LH as well as GnRH receptor mRNAs, but not the beta subunit of FSH. Administration of gonadotropin releasing hormone results in the secretion of LH. It provides a unique tool to study the cellular mechanisms involved in gonadotrope function, as well as a model to study the relationship between the control of the cell cycle and the regulation of differentiation. (See reference.) |
| SD1997-016 | Cell Line to Monitor HIV Infection Using Green Fluorescent Protein | UC San Diego inventors have developed a T cell line (CEM) containing the green fluorescent protein (GFP) to easily monitor HIV infection. Unlike the P24 antigen assay, which is expensive and time consuming, and plaque assays, which are also expensive to use, this cell line allows accurate and cost effective monitoring of HIV infection. The cell line contains a plasmid, pEGFP-1, with the humanized S65T GFP driven by the HIV-1 long terminal repeat. HIV infection induces fluorescence up to a 1000-fold higher than background. This cell line has a very low constitutive fluorescence and has extremely high sensitivity to HIV infection. Expression of the GF protein correlates to both p24 and gp 120 expression. It can be used to monitor viral loads, measure efficiency of therapeutic agents, assess emergence of drug resistance isolates from patients, or determine the infectivity of viral isolates. The fluorescent assays can be performed using standard clinical laboratory equipment such as a fluorescent activated flow cytometer, a cytofluorimeter or a fluorescence microscope. |
| Mice | ||
| Case No. | Title | Description |
| SD2010-090 | Mouse Models of Cryophrin Associated Periodic Syndromes | The inventors describe three different knock-in mice, each with a specific mutation associated with different disease phenotypes relating to cryopyrin associated periodic syndromes: familial cold autoinflammatory syndrome, Muckle Wells Syndrome, and neonatal onset multisystem inflammatory disease. These mouse models allow genetic studies of the human disease as well as to study pharmacologic compounds that may be useful for treatment. |
| SD2009-009 | Transgenic Mice Over-Expressing Caveolin-3 (M-Caveolin) within the Cardiac Myocyte | Technology Description: Caveolins are the principal protein components of caveolae, or “little caves,” which are 50 to 100 nm invaginations found in most cell types and represent appendages or subcompartments of plasma membranes. UC San Diego researchers have created a transgenic mouse for over-expressing caveolin-3 (M-caveolin) specifically within the cardiac myocyte. Caveolin-3 is one of the proteins that regulate signaling pathways and is thought to function in cardiac protection (ischemic preconditioning). Associated studies indicate that the novel caveolin-3 over-expressing mouse is resistant to myocardial ischemia/reperfusion injury, suggesting that caveolin-3 as a potential therapeutic for patients undergoing cardiac surgery or at high risk for myocardial infarction. |
| SD2007-157 | LysM-Cre/IKKBeta Flox Mice (Cre) | Inquiries To: invent@ucsd.edu |
| SD2007-149 | Mgat4a Type 1 Mice (Cre) |
Inquiries To: invent@ucsd.edu |
| SD2006-271 | TNFalpha Knock-Out Mice | Inquiries To: invent@ucsd.edu |
| SD2006-248 | JNK1/JNK2 KO Mice: JNK1+/-_JNK2-/- | Inquiries To: invent@ucsd.edu |
| SD2006-076 | Er Knock-Out Mice | Inquiries To: invent@ucsd.edu |
| SD2006-072 | IKKbeta/IKKalpha Knock- Out Mice | Inquiries To: invent@ucsd.edu |
| SD2005-033 | UGT1A Locus Transgenic Mice | Researchers at UC San Diego have developed a transgenic mouse that carries the entire UGT1A locus, over 250 kb of DNA, and found that it is regulated, like in man, in a tissue-specific and inducible fashion. These humanized mice are viable and the expression patterns have been characterized. By placing the gene locus into an in vivo environment that can be targeted by tissue-specific regulatory elements, it will be possible to examine the events involved in the control of the locus. |
| SD2005-007 | IKKBETA LOX/EE Mice | Inquiries To: invent@ucsd.edu |
| SD2005-006 | LYSM-CRE/IKKB LOXLOX/IL-1R+/- MICE | Inquiries to: invent@ucsd.edu |
| SD2005-005 | LYSM-CRE/IKKB LOX/LOX/TNFR1 +/- Mice | Inquiries to: invent@ucsd.edu |
| SD2004-256 | IKK BETA +/- Mice | Inquiries to: invent@ucsd.edu |
| SD2004-162 | Expression of Human CYP1A1 in Mice |
This invention is a transgenic mouse which carries the entire full-length human CYP1A1 gene plus the regulatory or flanking DNA. When the animals are exposed to certain environmental toxicants, the gene is induced through activation of the Aryl hydrocarbon (Ah) or dioxin receptor. Detection of gene expression can then be demonstrated by usual laboratory techniques such as enzymatic expression or Western blot. These mice are unique in that an entire human CYP1A1 gene is in a mouse. 1. These mice can be used to identify agents that induce the gene or activate the transcriptional regulator of the gene, i.e. toxicants. |
| SD2004-154 | Mouse Model of Crohn's Disease and a Method to Develop Specific Therapeutics | Inquiries To: invent@ucsd.edu |
| SD2004-144 | Animal Model to Detect the Presence of Environmental Toxicants | UC San Diego researchers have developed a transgenic mouse that carries a reporter gene, CYP1A1, constructed from the human gene P450 which is linked through its promoter and regulatory regions to a luciferase reporter gene. Previously, only mouse or rat CYP1A1 genes were used, this is the first example of a human CYP1A1 gene integrated into the mouse genome. Activation of the gene is conducted through the dioxin or Ah receptor. |
| SD2004-141 | LYSM-CRE/IKKBETA LOXLOX Mice | Inquiries To: invent@ucsd.edu |
| SD2004-140 | VILLIN-CRE/IKKBETA LOXLOX Mice | Inquiries To: invent@ucsd.edu |
| SD2004-125 | CaMKII Heart Failure and Arrythmic Mice |
Changes in intracellular calcium have been shown to be involved in multiple cardiomyocyte responses and are critical in the function of the heart. Calmodulin-dependent protein kinase II (CaMKII) is a transducer of calcium signals and is a significant component of cardiac function; changes in CaMKII have been shown to be associated with the development of heart failure. The enzyme acts by phosphorylating the ryanodine receptor, increasing the leakage of calcium from storage sites which are required for normal excitation-contraction coupling. Summary of the invention: Scientists at UC San Diego have developed transgenic mice which overexpress one of the isoforms of CaMKII. The mice develop dilated cardiomyopathy, diminished contractile function, premature lethality and heart failure. This model of arrythmia and death from heart failure is reproducible and is the result of known factors. The molecular basis of the model has been elucidated and it reproduces the situation seen in human heart failure. Further, in vitro studies have demonstrated that the pharmacological treatment of the transgene reverses the effect. Since the model so closely mimics the human arrythmias and heart failure, these mice could be useful in the discovery of new pharmacological agents for treating human cardiac disease and may provide a unique method for prevention and treatment of cardiac disease. |
| SD2004-133 | Mice Lacking IKK Beta in Intestinal Epithelial Cells | Mice Lacking IKK Beta in Intestinal Epithelial Cells—Models for Acute Organ Failure, Radiation Sensitivity, Colitis-Associated Cancer |
| SD2004-132 | Mice Lacking IKKß in Macrophages | Inquiries To: invent@ucsd.edu |
| SD2004-131 | Mice with a Conditional IKK Beta Loss of Function |
Inquiries To: invent@ucsd.edu |
| SD2004-130 | Mice Lacking IKK Beta in Liver Cells—Models for Acute Hepatic Failure, Hepatocellular Carcinoma and Increased Sensitivity to Insulin |
Inquiries To: invent@ucsd.edu |
| SD2004-129 | Enhancement of TH2-Dependent Anti-Inflammatory Response | Inquiries To: invent@ucsd.edu |
| SD2004-120 | IKK Beta Liver Knockout CRE Mice | Inquiries To: invent@ucsd.edu |
| SD2004-085 | In-Vivo Propagated Murine A20 Lymphoma Cells | Inquiries To: invent@ucsd.edu |
| SD2004-077 | Crossbred Mice : CK19CREXIKKBETA(LOX P) | Inquiries To: invent@ucsd.edu |
| SD2004-067 | In-Vivo Propagated Murine A20 Lymphoma Cells | Inquiries To: invent@ucsd.edu |
| SD2004-015 | IKKalpha +/- Mice | Inquiries To: invent@ucsd.edu |
| SD2003-069 | In Vivo Screening Models for Alzheimer's Disease | Transgenic mice expressing hBACEI have been generated and characterized behaviorally. This transgenic mouse model exists in several lines, each demonstrating an extensive neurological phenotype at early stages of development. Reversal of the phenotype with a known inhibitor has already been shown thus confirming the utility of this model for drug screening and validation. Reference: SD2003-069-JBC |
| SD2003-211 | IKK Alpha (AA) Mice | Inquiries To: invent@ucsd.edu |
| SD2003-195 | Floxed IKKB Mice | Inquiries To: invent@ucsd.edu |
| SD2003-189 | MEKK1 -/- MICE | Inquiries To: invent@ucsd.edu |
| SD2003-147 | New Mice: Crossbred JNK1 KO/JNK2 KO Mice | Inquiries To: invent@ucsd.edu |
| SD2003-004 | Knockout Mice Deleting Kinesin 3a | A knockout mouse line has been developed that has deleted the kinesin 3a ATPase. This knockout mouse is useful in the study of ATPase molecular motors, including their use as drug targets. |
| SD2002-230 | Knockout Mice Deleting 2a Subunit of Sodium Channel | A line of knockout mouse hase been developed that deletes the 2a subunit of the brain Na channel. This mouse model makes possible the modellingof a variety of neurologic disorders, drug target validation, and the screening of neuroactive drug candidates for efficacy, side effects and mechanism of action. |
| 2002-154 | IKKB+/-/TNFR-/- | Inquiries To: invent@ucsd.edu |
| SD2002-153 | IKKB LOX/LOX | Inquiries To: invent@ucsd.edu |
| SD2002-132 | P53 KnockoutT/DBA1 Mice as an Improved Model for Rheumatoid Arthritis | Collagen-induced arthritis has been used for many years as a model to evaluate potential therapeutic agents in arthritis. We have developed a strain of mice with more severe arthritis than standard collagen-induced arthritis. This strain has defective apoptosis in the joints and increased production of proteases and cytokines. Suggested Uses: This mouse model will be useful for identifying and developing therapeutic agents that induce apoptosis in arthritis, thereby overcoming the defect. In addition, it provides a more stringent test of anti-inflammatory agents and protease inhibitors because the disease is more severe and destructive than in presently available strains. |
| SD2002-121 | JUNAA, JUNWT Mice | Inquiries To: invent@ucsd.edu |
| SD2001-222 | Anti-Light Hybridoma Cell Line | Inquiries To: invent@ucsd.edu |
| SD2001-110 | IKK alpha -/-, IKK beta -/-, IKK gamma -/-, IKK Wild Type Cell Lines | Inquiries To: invent@ucsd.edu |
| SD2001-094 | Transgenic Mice with Deletion of mMGL. | UC San Diego
researchers have constructed transgenic mice with a
germline deletion of the mouse macrophage galactose/N-acetylgalactosamine-specific
C-type lectiin (mMGL). This lectin is normally expressed in monocytes,
macrophages, and dendritic cells.The deletion is maintained in C57BL/6 mice.
These transgenic animals are useful for research
on tumoricidal activity and innate immunity to certain
pathogens.
|
| SD2001-073 | Transgenic Mice Expressing FADDdd in T Cells
|
UC San Diego researchers and collaborators have constructed transgenic mice expressing the Fas-associating protein with a novel death domain, but without the death effector domain (e.g., FADDdd). This gene is under the control of p56lck. Experiments with these transgenic animals have shown that FADD plays a previously uncharacterized role in T cell development and activation. (See reference.) |
| SD2000-070 | Zp3-Cre Mice | Cre expression controlled by regulatory sequences of the Zp3 gene allowing for oocyte specificity. (See reference.) |
| SD2000-034 | Synapsin Cre Mice | These mice provice neuronal-specific Cre expression as controlled by the rat synapsin-1 promotor/enhancer. (See reference.) |
| SD1999-071 | MLC2A-Cre Mice | Inquiries To: invent@ucsd.edu |
| SD1999-091 | JNK1 and JNK2 Deficient Mice | Inquiries To: invent@ucsd.edu |
| Nucleic Acid Tools | ||
| Case No. | Title | Description |
| SD2008-278 | High-Level Expression of Proteins from a Stably Segregating B. Subtilis Plasmid | UC San Diego investigators have now discovered a sequence that allows a Bacillus subtilis plasmid vector to be stably maintained. It can be used to stably express heterologous proteins in B. subtilis, which was not achievable through plasmid expression before. This new vector contains a plasmid stability determinant functional in B. subtilis that makes it significantly more stable than any other vector available. |
| SD2005-186 | Optimizing Expression of Recombinant Protein in Mammalian Cells | Instead of modifying upstream promoter and enhancer elements, UC San Diego researchers have developed an innovative technology based on new insights on elements of a eukaryotic core promoter to achieve significantly higher expression of recombinant protein in mammalian cells. The inventors have designed, constructed, and optimized an extremely strong synthetic core promoter. They have demonstrated that an optimized synthetic core promoter can be at least four to five times stronger than currently widely used and known strongest promoters such as the adenovirus major late core promoter and the cytomegalovirus immediate early core promoter. This technology could greatly enhance the expression of a wide variety of recombinant proteins in mammalian cells, in vitro and in vivo. |
| SD2005-116 | Fluorescent Nucleoside Analogs that Mimic Naturally Occurring Nucleosides | Methods and compounds validated by incorporating into macromolecules and authenticating molecular behavior while monitoring fluorescence. Patent is pending. |
| SD2004-163 | Adenovirus Vector Encoding Human CD40 | Adenovirus vector, subtype 5 (Ad5) encoding human CD40. See publication below for additional details.
|
| SD2004-143 | DNA:GST-AtNOS1 Plasmid | UC San Diego inventors have identified and cloned a nitric oxide (NO) synthase gene from plants, AtNOS1, which has been shown to play a role in plant growth, stomatal movement, hormonal signaling and fertility. The protein was expressed in bacteria as a fusion protein with glutathione-S-transferase (GST-AtNOS1), purified and assayed. The inventors were able to show that extracts from bacteria expressing the fusion protein had higher levels of NOS activity. It is particularly interesting that this gene in plants has been known, but never isolated.
Applications: Agriculture companies may be interested in obtaining the plasmid for genetic manipulation of their plants to enhance leaf greening and growth, and regulation of stomatal opening and closure. In addition, basic researchers might want antibodies made against the specific plant nitric oxide synthase. |
| SD2003-207 | Genomic DNA from Bugula Neritina and Its Symbiont "Candiadtus Endobugula Sertula" |
|
| SD2003-256 | Plant Regulatory Gene, SIR1 | UC San Diego investigators have identified a key plant regulatory gene, SIR1, that works through the auxin signal transduction mechanism. The sir1 mutant is resistant to sirtinol, a small molecule that activates many auxin-inducible genes and promotes auxin-related developmental phenotypes. Auxins are plant hormones, universal in plants, that affect root and vascular development as well as many other aspects of plant growth. The cloned genes are available under Material Transfer Agreement. Related Materials: Zhao Y, Dai X, Blackwell HE, Schreiber SL, Chory J. SIR1, an upstream component in auxin signaling identified by chemical genetics. Science. 2003 Aug 22;301(5636):1107-10. |
| SD2003-146 | Modulation of Gene Transcription in Transgenic Organisms | UC San Diego investigators have discovered a new
way to modulate gene expression using genetics and a virus
sequence. This sequence, when incorporated into a target
gene, can be shown to have modulating effects upon transcription
in the presence of suppressing alleles placed in the same
genome. This modification of transcript levels has been
shown to work for mice, but could be applied to cell lines
as well as other transgenic organisms. Current methods
to modulate gene expression allow simple on or off in
a temporal fashion, or else rely on maintenance of a drug
regimen such as tetracycline.
Applications: As a research tool in organisms
from yeast to mice, or in cell lines, this method may
have a modulating effect upon gene expression rather
than a complete “on or off” switch. The
present approach allows multiple discrete allele strengths
to be obtained from a single transgene conditional upon
a second unlinked transgene, a chromosomal locus or
an expressed protein. |
| SD2003-115 | cDNA |
cDNA encoding mammalian molecular motor proteins KIF21A and KIF21B. |
| SD2003-023 | RNA Library from Drosophila Useful for Identification of Mammalian Signal Transduction Pathways | A library of RNA constructs has been developed by combining Drosophila and mammalian signaling pathway components, which is intended for use in identifying new signal transduction pathway components. |
| SD2001-080 | Plasmid for Testing Immune Receptors as Adjuvants | UC San Diego researchers have developed a plasmid, pNDK-OVA, which can be used to test soluble forms of different immune receptors as adjuvants in immunization protocols. The vector pNDK-OVA contains a 1161 bp fragment of the ovalbumin gene (OVA) obtained from pACB-OVA (reference: 1996.PNAS 93:5141) which has been inserted into pNDK. The vector pNDK vector is a pUC19-based plasmid which contains a kanamycin resistance gene, a cytomegalovirus (CMV) promoter enhancer sequence, a CMV immediate early intron and the bovine growth hormone (BGH) poly(A) signal. |
| SD2000-147 | Scavenger Receptor Promoter Sequences | Suppressor (S), enhancer (E),
and promoter (P) regions of the human scavenger receptor
for class A gene regulatory elements were used along with
a Human Growth Hormone reporter gene to generate SEP-H
and EP-H transgenes.
These transgenes can be used in the generation of transgenic mice to direct macrophage specific expression of foreign genes. (See reference.) |
| SD2000-078 | RNA Protection-Riboprobes for Studying Neurodegenerative Diseases. | UC San Diego researchers have developed over twenty-five different human, mouse, and rat riboprobes for use in RNase protection assays for the study of neurodegeneration associated with Altzheimer's and Parkinson's disease. These products are cloned into pCRII and can be removed by EcoRI digestion. Riboprobes have been developed for protection of these genes: excitatory amino acid transporters (EAAT), amyloid precursor protein (APP), synuclein (alpha, beta and gamma), synaptophysin, microtubule-associated protein 2 (MAP2), nuclear transport (RAN, Importin) and neural specific calmodulin-binding protein (mGAP43). Control riboprobes, for monitoring actin and dehydrogenase transcripts, have also been developed. These nucleic acid tools could be developed as part of a kit or as stand-alone reagents. |
SD2000-076 |
Pcre-Hygro Plasmid |
This plasmid can be used for
stable or transient expression of the cre recombinase.
*Use of this plasmid to generate transgenic mice requires the recipient to have a license with DuPont.
|
| SD2000-039 | pF/LOX Plasmid | For use in generating gene targeting
constructs via homologous recombination in embryonic stem
cells. It can be used to generate conditional or systemic
events. (See reference.)
*Use of this plasmid to generate transgenic mice requires the recipient to have a license with DuPont.
|
| SD2000-016 | Ovine VEGF cDNA | VEGF DNA was isolated from sheep placenta and various fetal tissues. A 164 amino acid peptide was the dominant form, with lower level of expression found of the 120 and 188 amino acid peptides. The VEGF164 signal peptide sequence is highly conserved. This cDNA is useful as a probe in Northern/Southern hybridization studies and for localization of VEGF mRNA in ovine tissues or cells. It can also be used in transfection experiments. (See reference.) |
| SD1999-153 | PV-1, an Endothelial Specific Protein and Its cDNA Clone | A UC San Diego researcher, along with researchers from sister academic institutions, have isolated from a caveolae-specific glycoprotein, named PV-1 and a cDNA encoding it from mouse and rat endothelial cells. PV-1 is an integral membrane protein of caveolae and appears to be expressed mostly in the lung, with little or no expression observed in the kidney, spleen, liver, heart, muscle and brain. PV-1 would be useful as a target for lung-specific drug delivery. |
| SD1999-110 | BAG1 and Its Homolog from Brassicaeae; Useful for Manipulation of Flower Structure |
Inquiries To: invent@ucsd.edu |
| SD1999-099 | Phage Display Expression Cloning Vector pJF3H | This vector offers increased frequency of functional inserts while minimizing the frequency of defective inserts because stop codons in the cDNA do not interfere with phage display. Cloning into this vector results in a c-terminal fusion product with the Fos protein and helper phage infection induces expression of the fusion product and the Jun-gpIII product. Selection is based on ampicillin resistance and expression is inducibile by the lac promotor. (See reference.) |
| SD1999-077 | Human Sodium Brain Channels (cDNA) | Although sodium channels often provide targets for various classes of drugs, studies of their molecular structure and specific pharmacology have been limited by the availability of tissue. Two full length cDNA (HBA AND HBB) clones specific for the sodium channel alpha subunit were isolated from cerebral cortex. The HBA clone has been expressed in CHO cells. These cDNA clones provide a new tool for the development of additional therapeutic compounds. (See reference.) |
| SD1998-051 | Human UGT Proteins (UDP-Glucuronosyltransferase) | Novel cDNAs taken from gastric tissue have been cloned and various products of the UDP-Glucuronosyltransferase gene expressed in a baculovirus system. These proteins are useful in the investigation of drug metabolism. They also have potential application in gene therapy studies for the treatment of the lethal negative mutation of the enzyme characteristic of Crigler-Najjar syndrome. (See reference.) |
| SD1998-045 | Novel Recombinant Adenovirus Vectors for Tissue Specific Gene Expression in Heart | UC San Diego researchers have developed a novel adenovirus vector which is useful for in vivo tissue-specific (e.g., cardiac muscle) expression of a transgene. Advantages for this technology are: Selected territories available. |
| SD1997-106 | Deformed Homeobox Proteins | Homeobox proteins are homeodomain-containing transcription factors which differentially regulate downstream gene expression important in morphological diversification. This antibody was raised against a full length recombinant Drosophila Dfd protein. The gene that encodes this protein is necessary for the development of the maxillary and mandibular segments of the fly head. (See reference.) |
| SD1993-414 | Tyrosine Kinase Produced from EGF |
Inquiries To: invent@ucsd.edu |
| SD2000-076 | Pcre-Hygro Plasmid | This plasmid can be used for
stable or transient expression of the cre recombinase.
(See reference.)
*Use of this plasmid to generate transgenic mice requires the recipient to have a license with DuPont. |
| Other Research Tools | ||
| Case No. | Title | Description |
| SD2009-181 | Defined Substrate for the Long-Term Maintenance of Human Embryonic Stem Cells | Technology Description: This invention provides a novel completely defined humanized substrate for sustaining the long-term culture of hESCs. HESCs grown on this matrix maintain their characteristic morphology, expression of pluripotency markers, genetic stability, and differentiation potential. |
| SD2008-006 | Reagents for Ultrasensitive, Ion Channel-Based Detection and Quantization | UC San Diego researchers developed proprietary compositions of matter and methods for synthesizing exquisitely sensitive, ion channel-based nanosensors. |
| SD2006-223 | Seedless Fruits and Flower Control Through Controlled Auxin Biosynthesis | UC San Diego investigators have identified the essential plant genes responsible for regulating the production of auxin, thus affecting many aspects of plant growth and development such as formation of floral organs, fruit development and vascular tissues. This work for the first time unambiguously identifies where auxin is synthesized in plants, thereby allowing the control of auxin gradients, a key in developmental regulation. |
| SD2005-155 | Optimizing Expression of Recombinant Protein in Mammalian Cells New Method for Promoting Nerve Regeneration | By studying pathways that play a crucial role in cell survival, plasticity and regeneration of neurons, UC San Diego researchers have identified a new use for a composition of matter that can promote nerve regeneration and protect neurons from apoptosis. The effectiveness of this compound is much better than neurotrophic factors, including BDNF or bFGF. In addition, the inventors have developed a novel delivery method to control the concentration of compound to achieve the maximal effect. The proof of concept has been demonstrated in animal model studies. This technology could be equally useful for the treatment of CNS or peripheral nerve injuries. |
| Protecting Groups with Increased Sensitivities | Protecting groups can be used to mask compounds, or portions of compounds, from interacting in chemical or biological systems.
|
|
| SD2003-103 | Blood Sample Library of Rare Leukemia Forms |
Blood sample library of rare leukemia forms. |
| SD2003-077 | Method for Monitoring and Detection of Translational Inhibition | Technology Description: UC San Diego investigators have designed in vitro system which measures changing fluorescence intensity during the translocation step of protein biosynthesis with exquisite sensitivity. The system is an excellent research tool for the study of microbial translocation and translation mechanisms. The sensitivity, adaptability and ease of the assay is superior to other standard assays for monitoring translocation of tRNA-mRNA on ribosomes, such as puromycin or toeprinting assays. |
| SD2001-192 | C5 Epimerase for Use in Polysaccharide Production | Background: Chemical-enzymatic
synthesis of commercially useful polysaccharides is hindered
by the lack of suitable enzyme preparations.
Technology Description: A glucuronic C5 epimerase suitable for use in production chemistry of complex polysaccharides has been sequenced and made available through its recombinant form. Cells transformed with the cDNA for this C5 epimerase are able to convert D-glucuronic acid to L-iduronic acid. Heparin and similar molecules in the cell are modified to iduronioc acid analogs, yielding modified glycans with differing properties. Advantages: The C-5 transformation of heparin and related molecules has not previously been practical to conduct in practical scale. State of Development: Preclinical Patent Information: Pending |
| SD2001-022 | Salinosporamide A: A Superior Proteasome Inhibitor | Marine organisms are a rich source of natural products with unique structures and potent biological activities. UC researchers have isolated and characterized one such product, Salinosporamide A (Sal A), which was discovered as a fermentation product from the marine actinomycete Salinispora tropica. By forming an irreversible, covalent adduct with the active site threonine of the 20S subunit of the proteasome, Sal A is able to potently and selectively inhibit all catalytic functions of the proteasome and thus represents a new biochemical tool that can be used to study basic cell biology or can be used as a standard for drug discovery programs targeting proteasome inhibition. |
| SD1999-153 | PV-1, an Endothelial Specific Protein and Its cDNA Clone | A UC San Diego researcher, along with researchers from sister academic institutions, have isolated from a caveolae-specific glycoprotein, named PV-1 and a cDNA encoding it from mouse and rat endothelial cells. PV-1 is an integral membrane protein of caveolae and appears to be expressed mostly in the lung, with little or no expression observed in the kidney, spleen, liver, heart, muscle and brain. PV-1 would be useful as a target for lung-specific drug delivery. |
| SD1999-121 | Floral Promoters | |
| SD1999-090 | Yeast Strains with Zinc Storage Mutations | Saccharomyces cerevisiae strains that carry a mutation in their vacuolar protein sorting demonstrate a temperature conditional defect. These mutant strains can be used as model systems for similar vacuole and Golgi functions in plants. (See reference.) |
| SD1998-123 | Prevention of Floral Petal Abscission in Transgenic Plants | The current invention involves the use of certain genes that control floral organ expression. By causing the over expression of these genes using transgenic technology, the process of floral petal abscission is blocked down stream of the regulatory point involving ethylene. This abscission is much sought after in the ornamental flower industry, as well as oil seed production and in may vegetable crops because chemical retardants and genetic manipulation of the ethylene pathway have proven only partially successful in preventing flower wilt and loss and prolonging flowering duration and shelf life. |
| SD1998-051 | UGT Proteins in Baculovirus Expression System | Inquiries To: invent@ucsd.edu |
| SD1997-010 | Regulatory Elements Used in the Expression of Cardiac SERC A2 | Inquiries to: invent@ucsd.edu |
| SD1996-001 | Protein Recruitment System | See patent number 5,776,689
For product information please refer to the Stratagene Web site. Click here to view a copy of the License Agreement. |
| SD1995-048 | Paw Thermal Stimulator | |
| SD1993-414 | Tyrosine Kinase Produced from EGF | Inquiries To: invent@ucsd.edu |